Page 10 - Kate Elder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Moderna, whose coronavirus vaccine appears to be the world’s best defense against COVID-19, has been supplying its shots almost exclusively to wealthy nations, keeping poorer countries waiting and earning billions in profit. After developing a breakthrough vaccine with the financial and scientific support of the U.S. government, Moderna has shipped a greater share of its doses to wealthy countries than any other vaccine manufacturer, according to Airfinity, a data firm that tracks vaccine shipments.

The global collaboration, set up early in the pandemic to give people in rich and poor nations equitable access to vaccines, has fallen short.

Advertisement Deaths from COVID-19 were surging across Africa in June when 100,000 doses of the Pfizer-BioNTech vaccine arrived in Chad. The delivery seemed proof that the United Nations-backed program to immunise the world could get the most desirable vaccines to the least developed nations. Yet five weeks later, Chad’s health minister said, 94,000 doses remained unused. Nearby in Benin, only 267 shots were being given each day, a pace so slow that 110,000 of the program’s AstraZeneca doses expired. Across Africa, confidential documents from July indicated, the program was monitoring at ...

Advertisement Deaths from COVID-19 were surging across Africa in June when 100,000 doses of the Pfizer-BioNTech vaccine arrived in Chad. The delivery seemed proof that the United Nations-backed program to immunise the world could get the most desirable vaccines to the least developed nations. Yet five weeks later, Chad’s health minister said, 94,000 doses remained unused. Nearby in Benin, only 267 shots were being given each day, a pace so slow that 110,000 of the program’s AstraZeneca doses expired. Across Africa, confidential documents from July indicated, the program was monitoring at ...

Let down by rich and failing the poor, global vaccine scheme to be shaken up Today 05:55 am JST Today | 07:04 am JST BRUSSELS Shunned by rich countries and failing to meet the needs of the poorest, a program co-led by the World Health Organization (WHO) for fair distribution of COVID-19 vaccines is planning a shake-up, internal documents seen by Reuters show. The COVAX program is far short of its target of delivering 2 billion doses by the end of the year, but does expect a big increase in supplies by early 2022, and wants to make sure that those, at least, reach the countr...